Publications & Congresses

All
Incoming Events
Year
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Use of Enzymatically Converted Cell-Free DNA (cfDNA) Data for Copy Number Variation-Linked Fragmentation Analysis Allows for Early Colorectal Cancer Detection
IJMS 2024
-
Mar 24, 2024
All events
This is some text inside of a div block.
This is some text inside of a div block.
Impact of cfDNA input on enzymatic methylation conversion and library preparation robustness
ISLB 2023
-
Nov 20, 2023
All events
This is some text inside of a div block.
This is some text inside of a div block.
Colorectal adenoma subtypes exhibit distinct molecular profiles- implications to early detection
ESMO Congress 2023
-
Oct 20, 2023
All events
This is some text inside of a div block.
This is some text inside of a div block.
Combining the methylation and gene expression contiguous signals leads to better pancreatic cancer patient stratification and early detection
2023 AACR SPECIAL CONFERENCE: PANCREATIC CANCER
-
Sep 27, 2023
All events
This is some text inside of a div block.
This is some text inside of a div block.
Specific Methylation Markers Associated with Changes in Gene Expression Distinguish EAC and Sub-Types of BE Patients
ISDE World Congress for Esophageal Diseases
-
Sep 9, 2023
All events
This is some text inside of a div block.
This is some text inside of a div block.
ESMO World Congress on Gastrointestinal Cancer 2023
ESMO Congress 2023
-
Jun 29, 2023
All events
This is some text inside of a div block.
This is some text inside of a div block.
Abstract: Large Multi-Cohort Study shows accurate detection of Early-Stage Colorectal Cancer and Advanced Adenoma Patients using cell-free DNA methylation and fragmentation signals
DDW Annual Meeting 2023
-
May 9, 2023
All events
This is some text inside of a div block.
This is some text inside of a div block.
Presentation: Large Multi-Cohort Study shows accurate detection of Early-Stage Colorectal Cancer and Advanced Adenoma Patients using cell-free DNA methylation and fragmentation signals
DDW Annual Meeting 2023
-
May 9, 2023
All events
This is some text inside of a div block.
This is some text inside of a div block.
Universal Diagnostics approach to early lung cancer detection at the 4th Annual Advances in Early Lung Cancer Detection Conference
4th Annual Advances in Early Lung Cancer Detection Conference
-
Apr 27, 2023
All events
This is some text inside of a div block.
This is some text inside of a div block.
Cell-free DNA (cfDNA) fragmentation profiles linked to copy number alteration analysis allows for early colorectal cancer detection
AACR Annual Meeting 2023
-
Apr 17, 2023
All events
This is some text inside of a div block.
This is some text inside of a div block.
Use of methylation and fragmentation signals in the detection of early-stage colorectal cancer
2023 ASCO GI Cancers Symposium
-
Jan 21, 2023
All events
This is some text inside of a div block.
This is some text inside of a div block.
Methylation biomarkers for colorectal cancer early detection and survival prognostics impact gene expression and link to cancer-related biological pathway
AACR Special Conference: Precision Prevention, Early Detection, and Interception of Cancer.
-
Nov 17, 2022
All events
This is some text inside of a div block.
This is some text inside of a div block.
Analysis of microbiome signatures in plasma for early CRC detection
ESMO Congress 2022
-
Sep 12, 2022
All events
This is some text inside of a div block.
This is some text inside of a div block.
Methylation Markers of Pancreatic Cancer categorization and prognosis evaluation
2022 ESMO World Congress on GI Cancer
-
Jun 30, 2022
All events
This is some text inside of a div block.
This is some text inside of a div block.
Accurate Detection of Colorectal Advanced Adenomas Through Analysis of Cell-free circulating tumor DNA (ctDNA) Methylation Patterns
EACR Virtual Congress
-
Jun 9, 2021
All events
This is some text inside of a div block.
This is some text inside of a div block.
Accurate early-stage colorectal cancer detection through analysis of cell-free circulating tumor DNA (ctDNA) methylation patterns
2021 ASCO Annual Meeting
-
Jun 4, 2021
All events
This is some text inside of a div block.
This is some text inside of a div block.
High throughput MSREqPCR for colon-cancer DNA-methylation biomarker testing
Molecular MedTri-Con Virtual Conference & Expo
-
Feb 16, 2021
All events
This is some text inside of a div block.
This is some text inside of a div block.
Cell-Free DNA (cfDNA) methylation assay allows for early detection and identification of lung cancer
IASLC 2020 World Conference on Lung Cancer Singapore
-
Jan 28, 2021
All events
This is some text inside of a div block.
This is some text inside of a div block.
Open Chromatin Region (OCR) based model predicts advanced adenoma in plasma cell-free DNA whole genome bisulfite sequencing data.
ESMO Virtual Congress 2020
-
Sep 19, 2020
All events
This is some text inside of a div block.
This is some text inside of a div block.
A panel of methylation makers for multi-cancer detection from plasma
ESMO Virtual Congress 2020
-
Sep 19, 2020
All events
This is some text inside of a div block.
This is some text inside of a div block.
Advanced colorectal adenoma detection based on altered methylation signal in plasma samples.
ESMO World Congress on Gastrointestinal Cancer
-
Jul 1, 2020
All events
This is some text inside of a div block.
This is some text inside of a div block.
Development and clinical performance of an accurate cell-free DNA (cfDNA) methylation assay for early detection of colorectal cancer.
AACR Advances in liquid biopsies
-
Jan 13, 2020
All events
This is some text inside of a div block.
This is some text inside of a div block.
MSRE-qPCR for analysis of gene specific methylation can be accurately used for detection and validation of colorectal cancer-specific patterns.
4BIO Summit: Europe
-
Nov 27, 2018
All events
This is some text inside of a div block.
This is some text inside of a div block.
Upcoming events will be displayed here.

Clinical Trials

We are collaborating with leading hospitals, integrated health systems, medical centers and biobanks around the world to conduct studies in order to further develop and validate UDX's blood test for early cancer detection.

+140

CLINICAL INSTITUTIONS

10

Countries

+14k

subjects RECRUITED

6

Studies

Signal-C® has initiated its clinical validation study in accordance with FDA requirements, with more than 15,000 patients. This validation study is expected to be completed by the mid 2025 . More information at ClinicalTrials.gov